ADVANCED ESOPHAGEAL CANCER
Clinical trials for ADVANCED ESOPHAGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED ESOPHAGEAL CANCER trials appear
Sign up with your email to follow new studies for ADVANCED ESOPHAGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a smart drug deliver a toxic payload directly to cancer cells?
Disease control Not yet recruitingThis early-phase trial is testing an experimental antibody-drug conjugate called MC002 in adults with advanced solid tumors, such as esophageal or lung cancer, that have progressed after standard treatments. MC002 is designed to target a protein found on cancer cells and deliver …
Matched conditions: ADVANCED ESOPHAGEAL CANCER
Phase: PHASE1 • Sponsor: Hangzhou MacroLink Biopharmaceutical LLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Fasting during immunotherapy: a new way to boost treatment?
Symptom relief Not yet recruitingThis study looks at whether intermittent fasting is safe and doable for people with advanced solid tumors who are starting immunotherapy. About 90 participants will be split into three groups: no fasting, eating only during an 8-hour window each day, or fasting every other day. R…
Matched conditions: ADVANCED ESOPHAGEAL CANCER
Phase: NA • Sponsor: West Virginia University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC